Quantcast

Latest Interventional cardiology Stories

2014-05-22 16:23:52

LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Intravascular Ultrasound (IVUS) Industryhttp://www.reportbuyer.com/pharma_healthcare/technology/intravascular_ultrasound_ivus.htmlThis report analyzes the worldwide markets for Intravascular Ultrasound (IVUS) in US$ Thousand by the following Product Segments: Intravascular Ultrasound (IVUS) Catheters, and Intravascular Ultrasound (IVUS) Consoles. The report provides separate...

2014-05-21 12:08:36

EuroPCR Optimizing treatment strategies is dependent on resources and geography A Great Debate at EuroPCR 2014 saw experts discussing the role of the two most valuable strategies to save the lives of ST-segment Elevation Myocardial Infarction (STEMI) patients: primary percutaneous coronary intervention (PCI) and thrombolysis. Both these are effective treatments that actively save lives, and when there is no option for primary percutaneous coronary intervention, thrombolysis is the...

2014-05-21 08:29:14

EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the SYNERGY(TM) Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium (PtCr) Coronary Stent System to the PROMUS Element(TM) Stent System. The data were presented today at EuroPCR 2014 by...

2014-05-20 23:15:46

Accreditation for Cardiovascular Excellence (ACE) accredits academic medical center renowned as the birthplace of percutaneous coronary intervention (PCI). Washington, DC (PRWEB) May 20, 2014 The Accreditation for Cardiovascular Excellence (ACE) is proud to announce that Emory University Hospital and Emory University Hospital Midtown, Atlanta, GA, are the latest facilities recognized with provisional accreditation by ACE. Both academic hospitals successfully completed the ACE...

2014-05-20 08:33:34

Company to Present at European Symposium Titled MGuard(TM) Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI BOSTON, May 20, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it will be attending EuroPCR 2014, the leading cardiovascular event in Europe. The conference will take place in Paris, France from May 20-23, 2014. Each year, more than 120...

2014-05-19 11:42:51

European Society of Cardiology Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. The study was presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology. Dr Masahiko Setoguchi said: "Sleeping problems are a frequent side effect of heart failure and it is common for...

2014-05-15 16:28:10

-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced the updated three- and two-year clinical outcomes from its DESSOLVE I and II clinical trials, respectively, will be presented at the EuroPCR conference to be held in Paris, France from May 20 - 23. Two oral presentations will be made by William Wijns, M.D., Ph.D., Cardiovascular Center, Aalst, Belgium: -- DESSOLVE II...

2014-05-15 12:33:31

CAESAREA, Israel, May 15, 2014 /PRNewswire/ -- Resources will be channeled towards randomized clinical studies and further commercialization. Keystone Heart will exhibit and present at EuroPCR next week in Paris. Keystone Heart, a medical device company and the developer of CE marked TriGuard(TM) Cerebral Protection Device [http://www.keystoneheart.com/products ], has successfully raised $14M in a series B round of financing led by OrbiMed. OrbiMed is a leading...

2014-05-09 08:26:52

FRAMINGHAM, Mass., May 9, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care Conference at 12:00 p.m. PDT (3:00 p.m. EDT) on Tuesday, May 13, 2014. The conference is being held May 12-15 at the Encore at...

2014-05-07 23:06:12

Market Size - $14.94 bn in 2013, Market Growth - CAGR of 7.7%, Market Trends – Growing demand for minimally invasive medical procedures. View complete report - http://www.grandviewresearch.com/industry-analysis/interventional-cardiology-devices-market-analysis. San Francisco, California (PRWEB) May 07, 2014 The global market for interventional cardiology devices is expected to reach USD 26.06 billion by 2020, according to a new study by Grand View Research, Inc. Growing global geriatric...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'